Transdermal Delivery of Chemotherapeutics: Strategies, Requirements, and Opportunities
Chemotherapeutic drugs are primarily administered to cancer patients via oral or parenteral routes. The use of transdermal drug delivery could potentially be a better alternative to decrease the dose frequency and severity of adverse or toxic effects associated with oral or parenteral administration...
Main Authors: | Rabin Neupane, Sai H. S. Boddu, Mariam Sami Abou-Dahech, Rinda Devi Bachu, David Terrero, R. Jayachandra Babu, Amit K. Tiwari |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/7/960 |
Similar Items
-
A mini-review on limitations associated with UV filters
by: Mariam Abou-Dahech, et al.
Published: (2022-11-01) -
Non-invasive transdermal delivery of chemotherapeutic molecules in vivo using superparamagnetic iron oxide nanoparticles
by: Vanisri Raviraj, et al.
Published: (2021-02-01) -
Invasome: A Novel Nanocarrier for Transdermal Drug Delivery
by: Soraya Babaie, et al.
Published: (2020-02-01) -
Alternatives to Biological Skin in Permeation Studies: Current Trends and Possibilities
by: Rabin Neupane, et al.
Published: (2020-02-01) -
pH-Sensitive Liposomes for Enhanced Cellular Uptake and Cytotoxicity of Daunorubicin in Melanoma (B16-BL6) Cell Lines
by: Hamad Alrbyawi, et al.
Published: (2022-05-01)